Literature DB >> 16892197

Model-free parameters from dynamic contrast-enhanced-MRI: sensitivity to EES volume fraction and bolus timing.

John A Jesberger1, Niusha Rafie, Jeffrey L Duerk, Jeffrey L Sunshine, Matthew Mendez, Scot C Remick, Jonathan S Lewin.   

Abstract

PURPOSE: To quantify the unknown relative sensitivities of semiquantitative measures from dynamic contrast-enhanced (DCE) MRI to variations in the volume fraction V(e) of the extravascular extracellular space (EES), and the duration of the contrast injection.
MATERIALS AND METHODS: Tissue-uptake curves were simulated across various values of F, PS, V(e), and bolus timings, with and without additive noise and at different image reacquisition rates. From each, the peak of the first derivative (G(peak)), the total uptake after the rapid first phase (CE), and the IAUC were calculated and plotted against F for each experimental condition. Relationships between each measure and the corresponding quantitative measure K(trans) were also examined, particularly for linearity.
RESULTS: The highest sensitivity to flow was achieved for shorter bolus timings for G(peak), CE, and IAUC. G(peak) and IAUC were most linearly related to K(trans). The sensitivity to V(e) was lowest for G(peak), followed by IAUC and CE. Long sampling intervals resulted in severe underestimation of G(peak), while IAUC was unaffected provided that the limits of integration were properly applied. G(peak) could not be properly calculated in the presence of noise without a prior smoothing of the acquired curves, while IAUC was again unaffected by noise.
CONCLUSION: G(peak) and IAUC are both useful model-free analogs of blood flow (i.e., K(trans)) for pre- and posttreatment comparisons. G(peak) may be the better choice in cases where larger changes in V(e) are likely, but only if sufficient noise reduction and fast image sampling are applied. If V(e) is expected to remain stable, IAUC is superior to G(peak) by virtue of its stability in the face of noise and more reliable estimation over a wider range of sampling rates.

Mesh:

Substances:

Year:  2006        PMID: 16892197     DOI: 10.1002/jmri.20670

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  8 in total

1.  Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.

Authors:  Chunhao Wang; Fang-Fang Yin; John P Kirkpatrick; Zheng Chang
Journal:  Technol Cancer Res Treat       Date:  2016-05-23

2.  Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer.

Authors:  Sang Ho Lee; Andreas Rimner; Emily Gelb; Joseph O Deasy; Margie A Hunt; John L Humm; Neelam Tyagi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-03-02       Impact factor: 7.038

3.  Dynamic Contrast-Enhanced MRI in Patients with Brain Metastases Undergoing Laser Interstitial Thermal Therapy: A Pilot Study.

Authors:  J I Traylor; D C A Bastos; D Fuentes; M Muir; R Patel; V A Kumar; R J Stafford; G Rao; S S Prabhu
Journal:  AJNR Am J Neuroradiol       Date:  2019-08-01       Impact factor: 3.825

4.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

5.  Multiparametric MR imaging of tumor response to intraarterial chemotherapy in orthotopic xenograft models of human metastatic brain tumor.

Authors:  Byungjun Kim; Keonha Kim; Keun Ho Im; Jae-Hoon Kim; Jung Hee Lee; Pyoung Jeon; Hongsik Byun
Journal:  J Neurooncol       Date:  2016-01-08       Impact factor: 4.130

6.  Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples.

Authors:  Thomas E Yankeelov; John C Gore
Journal:  Curr Med Imaging Rev       Date:  2009-05-01

7.  Dynamic contrast-enhanced magnetic resonance imaging for pretreatment prediction of early chemo-radiotherapy response in larynx and hypopharynx carcinoma.

Authors:  Wei Guo; Dehong Luo; Xinyi Chen; Meng Lin; Lin Li; Yanfeng Zhao; Liang Yang; Lei Hu; Xinming Zhao; Chunwu Zhou
Journal:  Oncotarget       Date:  2017-05-16

8.  Multimodality multiparametric imaging of early tumor response to a novel antiangiogenic therapy based on anticalins.

Authors:  Reinhard Meier; Rickmer Braren; Yvonne Kosanke; Johanna Bussemer; Frauke Neff; Moritz Wildgruber; Sarah Schwarzenböck; Annette Frank; Bernhard Haller; Andreas M Hohlbaum; Markus Schwaiger; Hendrik Gille; Ernst J Rummeny; Ambros J Beer
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.